Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study

NCT03549819 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

McMaster University

Collaborators